Prodromes and the early phase of the migraine attack: Therapeutic relevance

Functional Neurology

Volumn 20, Issue 4, 2005, Pages 179-183

  Buzzi, M Gabriella ^a   Cologno, Daniela ^a   Formisano, Rita ^a   Rossi, Palo ^b,c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b INI Grottaferrata   (Italy)

^c Polyclinic of Monza   (Italy)

Author keywords

Experimental model; Migraine pathogenesis; Premonitory symptoms; Treatment

Indexed keywords

APOMORPHINE; BIOLOGICAL MARKER; BROMOCRIPTINE; CHLORPROMAZINE; DIHYDROERGOCRYPTINE; DIHYDROERGOTAMINE; DOMPERIDONE; DOPAMINE; DROPERIDOL; FLUNARIZINE; GLYCEROL NITRATE; HALOPERIDOL; LISURIDE; METOCLOPRAMIDE; NARATRIPTAN; PIZOTIFEN; PLACEBO; PROCHLORPERAZINE; SEROTONIN; SEROTONIN ANTAGONIST;

ARTICLE; CLINICAL TRIAL; COMORBIDITY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MODEL; DOPAMINERGIC SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG MEGADOSE; ELECTROPHYSIOLOGY; HEADACHE; HUMAN; LOW DRUG DOSE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PAIN ASSESSMENT; PATHOGENESIS; PREDICTION; PREMENSTRUAL SYNDROME; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SYMPTOM;

FEMALE; HUMANS; MALE; MIGRAINE DISORDERS;

EID: 33645058405     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Amery WK, Wauquier A. The prelude to the migraine attack. London; Baillière Tindall 1986
2. Headache Classification of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96
3. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders (Second Edition). Cephalalgia 2004; 24:1-160
4. Blau JN. Migraine prodromes separated from the aura: complete migraine. Br Med J 1980;281:658-660
5. Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanism of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acadi Sci USA 2001;98:4687-4692
6. Facchinetti F, Martignoni E, Nappi G, Fioroni L, Sances G, Genazzani AR. Premenstrual failure of alpha-adrenergic stimulation on hypothalamus-pituitary responses in menstrual migraine. Psychosom Med 1989;51:550-558
7. Granella F, Sances G, Allais G et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004;24:707-716
8. O'Brien PM. Helping women with premenstrual syndrome. Br Med J 1993;307:1471-1475
9. Rasmussen BK, Olesen J. Migraine with aura and without aura: an epidemiological study. Cephalalgia 1992;12:221-228
10. Takeshima T, Ishizaki K, Fukuhara Y et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 2004;44:8-19
11. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A. Evoked potentials and transcranial magnetic stimulation in non published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 2003;114:955-972
12. Peroutka SJ. Dopamine and migraine. Neurology 1997; 49:650-656
13. Cerbo R, Barbanti P, Buzzi MG et al. Dopamine hypersensitivity in migraine: a role of the apornorphine test. Clin Neuropharmacol 1997;20:36-41
14. Waelkens J. Domperidone in the prevention of complete classical migraine. Br Med J (Clin Res Ed) 1982;284:944
15. Amery WK, Waelkens J. Prevention of the last chance: an alternative pharmacologic treatment of migraine. Headache 1983;23:37-38
16. Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984;4:85-90
17. Silberstein SD. The role of sex hormones in headache. Neurology 1992;42:37-42
18. Castillo J, Martinez F, Suarez C, Naveiro J, Lema M, Noya M. Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients. Cephalalgia 1996; 16:56-61
19. Giffin NJ, Ruggiero L, Lipton RB et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003;60:935-940
20. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 2004;110: 675-680
21. Barbanti P, Fabbrini G, Ricci A et al. Migraine patients show an increased density of domparnine D3 and D4 receptors on lymphocytes. Cephalalgia 2000;20:15-19
22. Barbanti P, Ricci A, Cerbo R et al. Increased expression of dopamine D5 receptors in peripheral blood lymphocytes in migraineurs. In: Clifford-Rose F ed New Advances in Headache Research 4. London; Smith-Gordon 1994:83-87
23. Barbanti P, Bronzetti E, Ricci A et al. Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine. Neurosci Lett 1996; 207:73-76
24. Del Zompo M, Cherchi A, Palmas MA et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998;51:781-786
25. Rebaudengo N, Rainero I, Parziale A et al. Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia 2004;24:503-507
26. Peres MF, Sanchez del Rio M, Seabra ML et al. Hypothalamic involvement in chronic migraine. JNNP 2001;71:747-751
27. Overeem S, van Vliet A Lammers GJ, Zitman FG, Swaab DF, Ferrari MD. The hypothalamus in episodic brain disorders. Lancet Neurol 2002;1:437-444
28. Bahra A, Matharu MS, Buchel, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-1017
29. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology 2000;54:308-313
30. Johnson SR. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet Gynecol 2004;104:845-859
31. Drummond PD. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalalgia 2002;22:117-124
32. Jaecques N, Lambert A, Schiettekatte L, Waelkens J. Treatment of nausea and vomiting during migraine attacks with intravenous domperidone. Postgrad Med J 1971;55 (Suppl 1):51
33. Massiou H. Dihydroergotamine nasal spray in prevention and treatment of migraine attacks: two controlled trials versus placebo. Cephalalgia 1987;7(Suppl 6):440-441
34. Jenzer G, Bremgartner MF. Dihydroergotamine as a nasal spray in the therapy of migraine attacks. Efficacy and tolerance. Schweiz Rundsch Med Prax 1990;79:914-917
35. Cerbo R, Formisano R, Falaschi P et al. Anterior pituitary hormone secretion during treatment with flunarizine in migrainous patients. Clin Neuropharmacol 1988;11:263-267
36. Luciani R, Carter D, Mannix L, Hemphill M, Diamond M, Cady R. Prevention of migraine during prodrome with naratriptan. Cephalalgia 2000;20:122-126